174 related articles for article (PubMed ID: 11462005)
1. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C
J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
[TBL] [Abstract][Full Text] [Related]
2. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115
[TBL] [Abstract][Full Text] [Related]
3. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
[TBL] [Abstract][Full Text] [Related]
4. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.
Dadaglio G; Moukrim Z; Lo-Man R; Sheshko V; Sebo P; Leclerc C
Infect Immun; 2000 Jul; 68(7):3867-72. PubMed ID: 10858196
[TBL] [Abstract][Full Text] [Related]
5. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein.
Préville X; Ladant D; Timmerman B; Leclerc C
Cancer Res; 2005 Jan; 65(2):641-9. PubMed ID: 15695409
[TBL] [Abstract][Full Text] [Related]
6. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
[TBL] [Abstract][Full Text] [Related]
8. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.
Saron MF; Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3314-9. PubMed ID: 9096390
[TBL] [Abstract][Full Text] [Related]
9. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
Fayolle C; Bauche C; Ladant D; Leclerc C
Vaccine; 2004 Dec; 23(5):604-14. PubMed ID: 15542180
[TBL] [Abstract][Full Text] [Related]
10. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
11. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
Simsova M; Sebo P; Leclerc C
Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
[TBL] [Abstract][Full Text] [Related]
13. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
Karimova G; Fayolle C; Gmira S; Ullmann A; Leclerc C; Ladant D
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12532-7. PubMed ID: 9770520
[TBL] [Abstract][Full Text] [Related]
14. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
[TBL] [Abstract][Full Text] [Related]
15. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitope.
Sebo P; Moukrim Z; Kalhous M; Schaft N; Dadaglio G; Sheshko V; Fayolle C; Leclerc C
FEMS Immunol Med Microbiol; 1999 Nov; 26(2):167-73. PubMed ID: 10536304
[TBL] [Abstract][Full Text] [Related]
16. Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara.
Mackova J; Stasikova J; Kutinova L; Masin J; Hainz P; Simsova M; Gabriel P; Sebo P; Nemeckova S
Cancer Immunol Immunother; 2006 Jan; 55(1):39-46. PubMed ID: 15926077
[TBL] [Abstract][Full Text] [Related]
17. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
[TBL] [Abstract][Full Text] [Related]
18. In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.
Guermonprez P; Fayolle C; Rojas MJ; Rescigno M; Ladant D; Leclerc C
Eur J Immunol; 2002 Nov; 32(11):3071-81. PubMed ID: 12385027
[TBL] [Abstract][Full Text] [Related]
19. Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines.
Sebo P; Osicka R; Masin J
Expert Rev Vaccines; 2014 Oct; 13(10):1215-27. PubMed ID: 25090574
[TBL] [Abstract][Full Text] [Related]
20. Bioengineering of
Chenal A; Ladant D
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30037010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
